Skip to main content
Carl Zeiss Meditec AG
back
Carl Zeiss Meditec AG
recommended searches
popular searches
Carl Zeiss Meditec AG
Annual Report 2024/25

Expanding Markets.

Transforming Healthcare
To the Annual Report

Financial Publications

New products are the key to our company's success. This innovative strength is the driving force of our growth. In this section we present facts and figures on the company's financial position.

Downloads

Key Financial Figures

2024/25
2023/24
2022/23

€m

%

€m

%

€m

%

Revenue

2.227,6

100

2.066,1

100  

2.089,3

100

Research and development expenses

326,3

14,6

343,1

16,6

349,3

16,7

EBITA

257,7
 

11,6

194,5 

9,4

348,1

16,7

Consolidated profit1

142,3

6,3

180,2

8,7

292,0

14,0

Earnings per share2
(in €)

1,61

2,01

3,25

Dividend per share
(in €)

0,55³

0,603

1,103

Cash flows from operating activities
  

209,9

247,3

250,9

Cash flows from investing activities
  

-91,0

-412,3

-111,0

Cash flows from financing activities

-108,8

176,2

-135,1

Total assets
  

3.403,4

100

3.393,2

100  

3.032,9

 

100

Property, plant and equipment

343,0
 

10,1

353,8

10,4

315,8

10,4

Equity

2.127,7

62,5

2.056,5

60,6

2,172,9

71,6

Net financial debt4

-276,9

-327,4

863,8

Employees (number)

5.784

5.726

4.832

Request investor information

  • 1

    Before non-controlling interests
  • 2

    Profit/loss per share attributable to the shareholders of the parent company in the fiscal year
  • 3

    Amount of dividend for proposed by the Supervisory Board and the Management Board of Carl Zeiss Meditec AG
  • 4

    Cash and cash equivalents plus treasury receivables from/payables to the treasury of Carl Zeiss AG